Literature DB >> 16186384

Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function.

Stella Papadopoulou1, Helena Edlund.   

Abstract

Mesenchymal-epithelial interactions are pivotal for proper pancreatic growth and development. We have earlier shown that the fibroblast growth factor (FGF) receptor 2 is expressed in pancreatic progenitor cells and that FGF10, the high-affinity ligand of the FGF receptor 2 isoform FGF receptor 2b, promotes expansion of pancreatic progenitors. The Wnt family of ligands, which signal to the Frizzled (Frz) type receptors, have also been shown to mediate mesenchymal-epithelial interactions and cell proliferation in a variety of different systems. Here, we show that Frz3, like FGF receptor 2, is expressed in the pancreatic epithelium during the proliferative phase of the embryonic pancreas in mice and that overexpression of a dominant-negative form of mouse Frz8 in pancreatic progenitors severely perturbs pancreatic growth. Nevertheless, the transgenic mice remain normoglycemic and display normal glucose tolerance and glucose-stimulated insulin secretion when challenged with exogenous glucose. The maintenance of normoglycemia in these mice appears to be the consequence of a relative increase in endocrine cell number per pancreatic area combined with enhanced insulin biosynthesis and insulin secretion. Collectively, our data provide evidence that Wnt signaling is required for pancreatic growth but not adult beta-cell function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16186384     DOI: 10.2337/diabetes.54.10.2844

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  71 in total

Review 1.  Pancreatic ductal adenocarcinoma and transcription factors: role of c-Myc.

Authors:  Anouchka Skoudy; Inmaculada Hernández-Muñoz; Pilar Navarro
Journal:  J Gastrointest Cancer       Date:  2011-06

Review 2.  Molecular function of TCF7L2: Consequences of TCF7L2 splicing for molecular function and risk for type 2 diabetes.

Authors:  Ola Hansson; Yuedan Zhou; Erik Renström; Peter Osmark
Journal:  Curr Diab Rep       Date:  2010-12       Impact factor: 4.810

Review 3.  Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

Authors:  M A Daniels; C Kan; D M Willmes; K Ismail; F Pistrosch; D Hopkins; G Mingrone; S R Bornstein; A L Birkenfeld
Journal:  Pharmacogenomics J       Date:  2016-07-19       Impact factor: 3.550

4.  TCF7L2 and type 2 diabetes--we WNT to know.

Authors:  U Smith
Journal:  Diabetologia       Date:  2006-11-11       Impact factor: 10.122

Review 5.  On the origin of the beta cell.

Authors:  Jennifer M Oliver-Krasinski; Doris A Stoffers
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

6.  Regulation of insulin secretion, glucokinase gene transcription and beta cell proliferation by adipocyte-derived Wnt signalling molecules.

Authors:  S Schinner; F Ulgen; C Papewalis; M Schott; A Woelk; A Vidal-Puig; W A Scherbaum
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

7.  The what, where, when and how of Wnt/β-catenin signaling in pancreas development.

Authors:  L Charles Murtaugh
Journal:  Organogenesis       Date:  2008-04       Impact factor: 2.500

8.  Analysis of mPygo2 mutant mice suggests a requirement for mesenchymal Wnt signaling in pancreatic growth and differentiation.

Authors:  Nicolas Jonckheere; Erin Mayes; Hung-Ping Shih; Boan Li; Oleg Lioubinski; Xing Dai; Maike Sander
Journal:  Dev Biol       Date:  2008-03-20       Impact factor: 3.582

9.  Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia.

Authors:  Daruneewan Warodomwichit; Donna K Arnett; Edmond K Kabagambe; Michael Y Tsai; James E Hixson; Robert J Straka; Michael Province; Ping An; Chao-Qiang Lai; Ingrid Borecki; Jose M Ordovas
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

10.  Lack of beta-catenin in early life induces abnormal glucose homeostasis in mice.

Authors:  S Dabernat; P Secrest; E Peuchant; F Moreau-Gaudry; P Dubus; N Sarvetnick
Journal:  Diabetologia       Date:  2009-06-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.